Eli Lilly Comprehensive Income 2010-2024 | LLY

Eli Lilly comprehensive income for the quarter ending June 30, 2024 was $-4.379B, a 15.57% increase year-over-year.

  • Eli Lilly comprehensive income for 2023 was $-4.327B, a 12.55% increase from 2022.
  • Eli Lilly comprehensive income for 2022 was $-3.845B, a 11.48% decline from 2021.
  • Eli Lilly comprehensive income for 2021 was $-4.343B, a 33.15% decline from 2020.

Eli Lilly Comprehensive Income 2010-2024 | LLY

  • Eli Lilly comprehensive income for 2023 was $-4.327B, a 12.55% increase from 2022.
  • Eli Lilly comprehensive income for 2022 was $-3.845B, a 11.48% decline from 2021.
  • Eli Lilly comprehensive income for 2021 was $-4.343B, a 33.15% decline from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Pfizer (PFE)$168.6B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B